Incidence, Risk Factors, and Impact of Severe Neutropenia After Hyperthermic Intraperitoneal Mitomycin C

Background Cytoreductive surgery (CRS) and hyperthermic intraperitoneal chemotherapy (HIPEC) are considered the standard of care for patients with peritoneal dissemination of appendiceal cancer and are increasingly being evaluated for use in patients with carcinomatosis from colon cancer. Mitomycin...

Ausführliche Beschreibung

Gespeichert in:

Bibliographische Detailangaben
Veröffentlicht in:	Annals of surgical oncology 2009-08, Vol.16 (8), p.2181-2187
Hauptverfasser:	Lambert, Laura A., Armstrong, Terri S., Lee, J. Jack, Liu, Suyu, Katz, Matthew H. G., Eng, Cathy, Wolff, Robert A., Tortorice, Melissa L., Tansey, Pier, Gonzalez-Moreno, Santiago, Lambert, Donald H., Mansfield, Paul F.
Format:	Artikel
Sprache:	eng
Schlagworte:	Adult Aged Antibiotics, Antineoplastic - adverse effects Appendiceal Neoplasms - drug therapy Appendiceal Neoplasms - pathology Combined Modality Therapy Female Gastrointestinal Oncology Humans Hyperthermia, Induced Incidence Infusions, Parenteral Injections, Intraperitoneal Male Medicine Medicine & Public Health Middle Aged Mitomycin - adverse effects Neoplasm Staging Neutropenia - chemically induced Neutropenia - drug therapy Neutropenia - pathology Oncology Retrospective Studies Risk Factors Surgery Surgical Oncology Treatment Outcome
Online-Zugang:	Volltext
Tags:	Tag hinzufügen Keine Tags, Fügen Sie den ersten Tag hinzu!

Schreiben Sie den ersten Kommentar!